127
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer

, &
Pages 6503-6520 | Published online: 05 Sep 2017

References

  • AlberghinaLChiaradonnaFVanoniMSystems biology and the molecular circuits of cancerChembiochem20045101322133315457529
  • FearonERHuman cancer syndromes: clues to the origin and nature of cancerScience19972785340104310509353177
  • VogelsteinBKinzlerKWCancer genes and the pathways they controlNat Med200410878979915286780
  • SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin201565152925559415
  • American Cancer Society IncBreast Cancer Facts & Figures 2015–2016AtlantaAmerican Cancer Society Inc2015
  • OlszewskiUHamiltonGA better platinum-based anticancer drug yet to come?Anticancer Agents Med Chem201010429330120187870
  • DiyabalanageHVGrandaMLHookerJMCombination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerCancer Lett201332911823032720
  • ZhangXFYanQShenWGurunathanSTrichostatin A enhances the apoptotic potential of palladium nanoparticles in human cervical cancer cellsInt J Mol Sci2016178 pii:E1354
  • ChaoMWLaiMJLiouJPThe synergic effect of vincristine and vorinostat in leukemia in vitro and in vivoJ Hematol Oncol201588226156322
  • ThurnKThomasSRahaPQureshiIMunsterPNInhibition of class I histone deacetylases attenuates anthracycline induced activation of the ATM pathwayCancer Res2011718 Suppl Abstract 2614
  • PetruccelliLADupere-RicherDPetterssonFRetrouveyHSkoulikasSMillerWHJrVorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cellsPLoS One201166e2098721695163
  • OkadaMLeeLMaekawaREpigenetic changes of the Cyp11a1 promoter region in granulosa cells undergoing luteinization during ovulation in female ratsEndocrinology201615793344335427428926
  • RosikLNiegischGFischerUJungMSchulzWAHoffmannMJLimited efficacy of specific HDAC6 inhibition in urothelial cancer cellsCancer Biol Ther201415674275724618845
  • MishraSKMandalMMazumdarAKumarRDynamic chromatin remodeling on the HER2 promoter in human breast cancer cellsFEBS Lett20015071889411682064
  • AriffinJKdas GuptaKKapetanovicRHistone deacetylase inhibitors promote mitochondrial reactive oxygen species production and bacterial clearance by human macrophagesAntimicrob Agents Chemother20156031521152926711769
  • FalkenbergKJJohnstoneRWHistone deacetylases and their inhibitors in cancer, neurological diseases and immune disordersNat Rev Drug Discov201413967369125131830
  • LiZZhuWGTargeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implicationsInt J Biol Sci201410775777025013383
  • ZhangJZhongQHistone deacetylase inhibitors and cell deathCell Mol Life Sci201471203885390124898083
  • DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • GurunathanSHanJWEppakayalaVJeyarajMKimJHCytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cellsBiomed Res Int2013201353579623936814
  • GurunathanSKimEHanJWParkJHKimJHGreen chemistry approach for synthesis of effective anticancer palladium nanoparticlesMolecules20152012224762249826694334
  • WuXJZhouLZSuYDongCMAn autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapyJ Mater Chem B201641221422152
  • CooksonJThe Preparation of Palladium NanoparticlesPlatin Met Rev20125628398
  • AstrucDPalladium nanoparticles as efficient green homogeneous and heterogeneous carbon-carbon coupling precatalysts: a unifying viewInorg Chem20074661884189417348719
  • SemaginaNRenkenAKiwi-MinskerLPalladium nanoparticle size effect in 1-hexyne selective hydrogenationJ Phys Chem C2007111371393313937
  • DimitratosNPortaFPratiLVillaASynergetic effect of platinum or palladium on gold catalyst in the selective oxidation of D-sorbitolCatal Lett2005993–4181185
  • BellerMFischerHKühleinKReisingerCPHerrmannWAFirst palladium-catalyzed Heck reactions with efficient colloidal catalyst systemsJ Organomet Chem19965201–2257259
  • CheongSSWattJDTilleyRDShape control of platinum and palladium nanoparticles for catalysisNanoscale20102102045205320694209
  • AnhTDAhnMYKimSAYoonJHAhnSGThe histone deacetylase inhibitor, trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cellsOncol Rep201227245546021993600
  • GurunathanSJeongJKHanJWZhangXFParkJHKimJHMultidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cellsNanoscale Res Lett2015103525852332
  • GurunathanSRamanJMalekNAJohnPAVikineswarySGreen synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cellsInt J Nanomed2013843994413
  • MahdiehMZolanvariAAzimeeASMahdiehMGreen biosynthesis of silver nanoparticles by Spirulina platensisSci Iran2012193926929
  • PatelVBertholdDPuranikPGantarMScreening of cyanobacteria and microalgae for their ability to synthesize silver nanoparticles with antibacterial activityBiotechnol Rep20155112119
  • BekasovaODBrekhovskikhAARevinaAADubinchukVTPreparation and optical properties of silver nanoparticles in R-phycoerythrin, a protein matrixInorg Mater2008448835841
  • ShenyDSPhilipDMathewJRapid green synthesis of palladium nanoparticles using the dried leaf of Anacardium occidentaleSpectrochim Acta A Mol Biomol Spectrosc201291353822349890
  • KhanMKhanMKuniyilMBiogenic synthesis of palladium nanoparticles using Pulicaria glutinosa extract and their catalytic activity towards the Suzuki coupling reactionDalton Trans201443249026903124619034
  • NadagoudaMNVarmaRSGreen synthesis of silver and palladium nanoparticles at room temperature using coffee and tea extractGreen Chem2008108859862
  • XuWSParmigianiRBMarksPAHistone deacetylase inhibitors: molecular mechanisms of actionOncogene200726375541555217694093
  • ChangJVargheseDSGillamMCDifferential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptideBr J Cancer2012106111612522158273
  • YanGEllerMSElmCSelective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cellsJ Invest Dermatol2013133102444245223698071
  • ChanSTYangNCHuangCSLiaoJWYehSLQuercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivoPLoS One201381e5425523342112
  • ZhangYWZhengYWangJZIntegrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancerEpigenetics20149689690924699858
  • KaliszczakMTrousilSAbergOPerumalMNguyenQDAboagyeEOA novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growthBr J Cancer2013108234235023322205
  • SinghTPrasadRKatiyarSKInhibition of class I histone deacetylases in non-small cell lung cancer cells by honokiol leads to suppression of cancer cell proliferation and induction of cell death in vitro and in vivo modelsEpigenetics201381546523221619
  • ZhangXJiangSJShangBJiangHJEffects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell lineThorac Cancer20156220220826273359
  • NetalaVRBethuMSPushpalathaBBiogenesis of silver nanoparticles using endophytic fungus Pestalotiopsis microspora and evaluation of their antioxidant and anticancer activitiesInt J Nanomedicine2016115683569627826190
  • NaoraHNishidaTShindoYAdachiMNaoraHConstitutively enhanced nbl expression is associated with the induction of internucleosomal DNA cleavage by actinomycin DBiochem Biophys Res Commun199622412582648694823
  • NikiTRomboutsKDe BleserPA histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary cultureHepatology199929385886710051490
  • CarewJSGilesFJNawrockiSTHistone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapyCancer Lett2008269171718462867
  • RosatoRRGrantSHistone deacetylase inhibitors: insights into mechanisms of lethalityExpert Opin Ther Targets20059480982416083344
  • RahmaniMReeseEDaiYBauerCPayneSGCoadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen speciesCancer Res2005652422243215781658
  • LouisMRosatoRRBraultLThe histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stressInt J Oncol20042561701171115547708
  • RosatoRRAlmenaraJAGrantSThe histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21 (CIP1/WAF1)Cancer Res200363133637364512839953
  • RosatoRRAlmenaraJAMaggioSCRole of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsMolecular Cancer Ther200871032853297
  • RuefliAAAusserlechnerMJBernhardDThe histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen speciesP Natl Acad Sci U S A200198191083310838
  • KalyanaramanBTeaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanismsRedox Biol20131124425724024158
  • UngerstedtJSSowaYXuWSRole of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitorsProc Natl Acad Sci U S A2005102367367815637150
  • HoEKarimi GalougahiKLiuCCBhindiRFigtreeGABiological markers of oxidative stress: applications to cardiovascular research and practiceRedox Biol2013148349124251116
  • YouBRParkWHSuberoyl bishydroxamic acid-induced apoptosis in HeLa cells via ROS-independent, GSH-dependent mannerMol Biol Rep20134053807381623269626
  • BrechbuhlHMKachadourianRMinEChanDDayBJChrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathioneToxicol Appl Pharmacol201225811921856323
  • FathMAAhmadIMSmithCJSpenceJSpitzDREnhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolismClin Cancer Res201117196206621721844013
  • SchnelldorferTGansaugeSGansaugeFSchlosserSBegerHGNusslerAKGlutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cellsCancer20008971440144711013356
  • MiriyalaSSpasojevicITovmasyanAManganese superoxide dismutase, MnSOD and its mimicsBiochim Biophys Acta20121822579481422198225
  • SenaLAChandelNSPhysiological roles of mitochondrial reactive oxygen speciesMol Cell201248215816723102266
  • PeartMJTaintonKMRuefliAANovel mechanisms of apoptosis induced by histone deacetylase inhibitorsCancer Res200363154460447112907619
  • JiangSJDowdySCMengXWHistone deacetylase inhibitors induce apoptosis in both type I and type II endometrial cancer cellsGynecol Oncol2007105249350017303224
  • SunBBFuLNWangYQSilencing of JMJD2B induces cell apoptosis via mitochondria-mediated and death receptor-mediated pathway activation in colorectal cancerJ Dig Dis201415949150024957706
  • ZhouWQFengXYHanHGuoSCWangGDSynergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cellsSci Rep201662800427292433
  • OkadaKHakataSTerashimaJGamouTHabanoWOzawaSCombination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cellsOncol Rep20163641875188527509880
  • WolfBBGreenDRSuicidal tendencies: apoptotic cell death by caspase family proteinasesJ Biol Chem199927429200492005210400609
  • WolfBBSchulerMEcheverriFGreenDRCaspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivationJ Biol Chem199927443306513065610521451
  • LeeEFurukuboTMiyabeTYamauchiAKariyaKInvolvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosisFEBS Lett19963952–31831878898091
  • BoldenJEPeartMJJohnstoneRWAnticancer activities of histone deacetylase inhibitorsNat Rev Drug Discov20065976978416955068
  • GlozakMASenguptaNZhangXHSetoEAcetylation and deacetylation of non-histone proteinsGene2005363152316289629
  • MarksPADokmanovicMHistone deacetylase inhibitors: discovery and development as anticancer agentsExpert Opin Investig Drugs2005141214971511
  • MinucciSPelicciPGHistone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNat Rev Cancer200661385116397526
  • ZhaoYTanJZhuangLJiangXLiuETYuQInhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein BimProc Natl Acad Sci U S A200510244160901609516243973
  • ZhangXDGillespieSKBorrowJMHerseyPThe histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cellsMol Cancer Ther20043442543515078986
  • XuWNgoLPerezGDokmanovicMMarksPAIntrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitorProc Natl Acad Sci U S A200610342155401554517030815
  • RosatoRRMaggioSCAlmenaraJAThe histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramideMol Pharmacol200669121622516189296
  • JiangXJWangXDCytochrome C-mediated apoptosisAnnu Rev Biochem2004738710615189137
  • YangXMShiZLZhangNSuberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cellsCancer Cell Int20141410725729327
  • HanMHParkCKwonTKThe histone deacetylase inhibitor trichostatin A sensitizes human renal carcinoma cells to TRAIL-induced apoptosis through down-regulation of c-FLIPLBiomol Ther (Seoul)2015231313825593641